Inovio Pharmaceuticals
INO
#9427
Rank
โ‚ฌ82.03 M
Marketcap
1,01ย โ‚ฌ
Share price
2.59%
Change (1 day)
-33.48%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,43ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,34ย โ‚ฌ an increase over its 2023 EPS that were of -5,15ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-24.21%
2024-3,34ย โ‚ฌ-35.14%
2023-5,15ย โ‚ฌ-56.62%
2022-11,86ย โ‚ฌ-19.54%
2021-14,74ย โ‚ฌ35.9%
2020-10,85ย โ‚ฌ-11.57%
2019-12,27ย โ‚ฌ15.24%
2018-10,65ย โ‚ฌ-2.78%
2017-10,95ย โ‚ฌ6.93%
2016-10,24ย โ‚ฌ134.88%
2015-4,36ย โ‚ฌ-29.51%
2014-6,18ย โ‚ฌ-57.34%
2013-14,50ย โ‚ฌ146.55%
2012-5,88ย โ‚ฌ20.83%
2011-4,87ย โ‚ฌ-29.41%
2010-6,89ย โ‚ฌ-48.48%
2009-13,38ย โ‚ฌ10%
2008-12,17ย โ‚ฌ11.11%
2007-10,95ย โ‚ฌ-41.3%
2006-18,66ย โ‚ฌ-66.91%
2005-56,37ย โ‚ฌ110.61%
2004-26,77ย โ‚ฌ-61.63%
2003-69,75ย โ‚ฌ186.67%
2002-24,33ย โ‚ฌ
2001N/A-100%
2000-19,47ย โ‚ฌ-63.54%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,41ย โ‚ฌ-486.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,08ย โ‚ฌ-350.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,15ย โ‚ฌ-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,79ย โ‚ฌ-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,18ย โ‚ฌ-353.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,18ย โ‚ฌ-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,30ย โ‚ฌ-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA